MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2026ACC: 0002012524-26-000002
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-16.85K
Net shares
Net seller
$331.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
16.85K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−16.85K
Price / share
$19.66
Trade value
$331.29K
% of position
8.4%
2/20/2026
201.01K→184.16K
Total
Net shares
−16.85K
Net value
-$331.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2026 | F · Tax Withholding | −16.85K | $19.66 | $331.29K | 8.4% | 201.01K | 184.16K |
| Total | −16.85K | -$331.29K | ||||||
Derivative Transactions0
No derivative transactions reported